Skip to main content
Gregory Friedman, MD, Pediatric Hematology & Oncology, Houston, TX

GregoryKFriedmanMD

Pediatric Hematology & Oncology Houston, TX

Pediatric Neuro-Oncology

Professor of Pediatrics

Dr. Friedman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Friedman's full profile

Already have an account?

  • Office

    1515 Holcombe Blvd
    Lowder 512
    Houston, TX 77030
    Phone+1 713-792-6620
    Fax+1 713-794-5042

Summary

  • Dr. Gregory Friedman is a pediatric hematologist/oncologist in Houston, TX and is affiliated with University of Texas M.D. Anderson Cancer Center. He received his medical degree from Medical College of Georgia and has been in practice 15 years. He specializes in pediatric neuro-oncology and is experienced in glioblastoma, medulloblastoma, immunotherapy, gliomas, and pediatric brain tumors. He has more than 90 publications and over 500 citings.

Education & Training

  • University of Alabama Medical Center
    University of Alabama Medical CenterFellowship, Pediatric Hematology/Oncology, 2005 - 2008
  • University of Alabama Medical Center
    University of Alabama Medical CenterResidency, Pediatrics, 2002 - 2005
  • Medical College of Georgia at Augusta University
    Medical College of Georgia at Augusta UniversityClass of 2002

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2023 - 2026
  • AL State Medical License
    AL State Medical License 2003 - 2023
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Original Article Stereotactic Placement of Intratumoral Catheters for Continuous Infusion Delivery of HSV-1 G207 in Pediatric Malignant Supratentorial Brain Tumors  
    Asim K Bag, G Yancey Gillespie, Gregory K Friedman, Zachary Wright, James M Markert, James M Johnston, ScienceDirect
  • UAB30, a Novel RXR Agonist, Decreases Tumorigenesis and Leptomeningeal Disease in Group 3 Medulloblastoma Patient-Derived Xenografts  
    Gregory K Friedman, Evan F Garner, Laura L Stafman, Journal of Neuro-Oncology

Press Mentions

  • Treovir Announces Opening of G207 Phase 2 Clinical Trial in Children with Recurrent Brain Tumors
    Treovir Announces Opening of G207 Phase 2 Clinical Trial in Children with Recurrent Brain TumorsDecember 4th, 2024
  • 2 Your Health: Study Links Gut Microbiome and Aggressive Prostate Cancer
    2 Your Health: Study Links Gut Microbiome and Aggressive Prostate CancerNovember 11th, 2021
  • UAB-Developed Viral Immunotherapy for Pediatric Brain Tumors Shows Promise
    UAB-Developed Viral Immunotherapy for Pediatric Brain Tumors Shows PromiseMay 2nd, 2021
  • Join now to see all